Faecal microbiota transplantation for recurrent Clostridioides difficile infection: an Australian experience - effective, safe, yet room for improvement

被引：2

作者：

Chauhan, Ayushi ^{[1
]}

Apostolov, Ross ^{[1
]}

van Langenberg, Daniel ^{[1
,2
]}

Garg, Mayur ^{[1
,2
,3
,4
]}

机构：

[1] Eastern Hlth, Dept Gastroenterol, Melbourne, Vic, Australia

[2] Monash Univ, Eastern Hlth Clin Sch, Melbourne, Vic, Australia

[3] Royal Melbourne Hosp, Dept Gastroenterol & Hepatol, Melbourne, Vic, Australia

[4] Univ Melbourne, Dept Med, Melbourne, Vic, Australia

来源：

INTERNAL MEDICINE JOURNAL | 2021年 / 51卷 / 01期

关键词：

faecal microbiota transplantation; Clostridioides difficile; host− microbiota interaction; immune‐ mediated illness; ANA;

D O I：

10.1111/imj.15162

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Faecal microbiota transplantation (FMT) is reportedly effective and safe for the management of recurrent or refractory Clostridioides difficile infection (CDI), yet real-world data of outcomes of FMT in Australia are limited. In this series, FMT safely resulted in resolution of CDI in 19 patients with reduced healthcare utilisation after 25 FMT, but one patient was diagnosed with an anti-nuclear antibody-positive constitutional illness and Hashimoto thyroiditis following FMT. Further prospective evaluation of the utility of FMT earlier in CDI treatment algorithms to minimise cost and morbidity, and recipient follow up for immune-mediated conditions, is required.

引用

页码：106 / 110

页数：5

共 50 条

[31] Health economic evaluations comparing faecal microbiota transplantation with antibiotics for treatment of recurrent Clostridioides difficile infection: a systematic review
Hammeken, Lianna Hede
Baunwall, Simon Mark Dahl
Hvas, Christian Lodberg
Ehlers, Lars Holger
HEALTH ECONOMICS REVIEW, 2021, 11 (01)
[32] Initial experience of the first Brazilian stool bank with fecal microbiota transplantation for recurrent Clostridioides difficile infection
Terra, D. A. A.
Coelho, L. V.
Vilela, E. G.
Silva, R. O.
Lima, K. S.
Leao, L. A.
Passos, R. I. F. A.
HELICOBACTER, 2020, 25 : 92 - 93
[33] ECONOMIC EVALUATION OF A FECAL MICROBIOTA TRANSPLANTATION PROGRAM FOR RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
Yang, David Y.
Mullie, Tom
Russell, Lindsey
Roach, Brandi
Wong, Karen
Kao, Dina H.
GASTROENTEROLOGY, 2019, 156 (06) : S1158 - S1158
[34] Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection: Efficacy and Predictors of Success
Abdallah, Mohamed
Abdalla, Abdelmohaymin
Wiedel, Noah
Baloun, Brett
Gilbert, Jorge
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S78 - S78
[35] Predictors and Management of Failed Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
Tariq, Raseen
Saha, Srishti
Solanky, Dipesh
Pardi, Darrell S.
Khanna, Sahil
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2021, 55 (06) : 542 - 547
[36] Real World Experience With Microbiota Treatment for the Prevention of Recurrent Clostridioides difficile Infection
Ritter, Timothy E.
Rosenberg, Jonathan A.
Hengel, Richard L.
Krishnan, Sujatha
Baker, Kathy A.
Van Anglen, Lucinda J.
Hanna, Kelly E.
Guo, Amy
Moosapanah, Mielad
Seo, Sanghyuk
Garey, Kevin W.
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S876 - S876
[37] Fecal microbiota transplantation: the need for effective treatment of Clostridioides difficile infection in Pakistan
Khurram, Subata
Asad, Ayesha
Fatima, Syeda Zainab
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2023, 17 (11): : 1626 - 1627
[38] Pediatric Fecal Microbiota Transplantation in Recurrent Clostridioides Difficile
Parnell, Jacob M.
Nicholson, Maribeth R.
Kellermayer, Richard
Kahn, Stacy A.
PEDIATRIC ANNALS, 2021, 50 (12): : E515 - E521
[39] Faecal microbiota transplantation for Clostridium difficile infection
Dodin, M.
Katz, D. E.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2014, 68 (03) : 363 - 368
[40] Fecal Microbiota Transplantation Is Effective for the Treatment of Partially Treated Clostridioides difficile Infection
Cho, Young-Seok
GUT AND LIVER, 2021, 15 (01) : 1 - 2

← 1 2 3 4 5 →